MTOR and breast cancer: In 2017, Pakravan et al. [172] reported, in breast cancer, that miR-100 transported in exosomes derived from mesenchymal stem cells (MSCs) suppressed angiogenesis through the regulation of the mTOR/HIF-1a/VEGF signaling axis in breast cancer cells.